Skip to main content
. 2016 Feb 18;8:43–52. doi: 10.2147/CEOR.S100921

Figure 4.

Figure 4

Estimation (in euro, €) of productivity (gain) loss with reversal of rocuronium-induced NMB by sugammadex administered for “preventive use” compared to neostigmine.

Notes: Chi-square tests were performed. Significance (*) was taken at P<0.05.

Abbreviation: NMB, neuromuscular blockade.